FIRM FIXED PRICE

MCKESSON CORPORATION - EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY

PIID: 36C24026K1004
Signed Date: Jan 1, 2026Effective Date: Jan 1, 2026End Date: Closed on Jan 31, 2026
Award $
$1.1B
Vendor
MCKESSON CORPORATION
NAICS
325412
Signed Date
Jan 1, 2026

Key Details

Dollars Obligated
$1.1B
Base & All Options
$1.1B
Awarding Sub-Agency
Department of Veterans Affairs
Product Service Code
6505 - DRUGS AND BIOLOGICALS
Extent Competed
FULL AND OPEN COMPETITION
Place of Performance
IRVING, TX, 750392402, CD-TX-33

Description

EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY

Context & Analysis

On Jan 1, 2026, Department of Veterans Affairs obligated $1,087,989,765.81 to MCKESSON CORPORATION for express report: pharmaceutical prime vendor (ppv)fy2026 january. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in IRVING, TX.

Contractor Information

UEI: S1RUKWWRYFL6
CAGE Code: 1MKG3
Location: IRVING, TX
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related